J. Safra Sarasin Holding AG acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the first quarter, Holdings Channel reports. The institutional investor acquired 3,652 shares of the financial services provider’s stock, valued at approximately $633,000.
Several other hedge funds also recently bought and sold shares of MRSH. Swiss Life Asset Management Ltd grew its holdings in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after purchasing an additional 11,648 shares in the last quarter. Sarasin & Partners LLP boosted its position in Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after buying an additional 8,283 shares during the period. Essex LLC acquired a new position in shares of Marsh & McLennan Companies in the first quarter worth $2,891,000. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Marsh & McLennan Companies by 20.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 88,934 shares of the financial services provider’s stock worth $16,499,000 after acquiring an additional 15,166 shares during the period. Finally, Benjamin Edwards Inc. raised its stake in shares of Marsh & McLennan Companies by 26.6% in the fourth quarter. Benjamin Edwards Inc. now owns 35,293 shares of the financial services provider’s stock valued at $6,549,000 after acquiring an additional 7,418 shares in the last quarter. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Wall Street Analysts Forecast Growth
MRSH has been the subject of several analyst reports. Mizuho boosted their target price on Marsh & McLennan Companies from $194.00 to $197.00 and gave the stock a “neutral” rating in a research note on Thursday, July 9th. Morgan Stanley decreased their price objective on Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating for the company in a research note on Monday, July 6th. Keefe, Bruyette & Woods upped their target price on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research note on Friday, April 17th. UBS Group raised their target price on shares of Marsh & McLennan Companies from $203.00 to $212.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Finally, Barclays lowered their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and an average target price of $200.81.
Insider Activity
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Trading Down 1.0%
Shares of Marsh & McLennan Companies stock opened at $176.29 on Thursday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $216.32. The company has a market capitalization of $85.17 billion, a price-to-earnings ratio of 22.04, a P/E/G ratio of 2.59 and a beta of 0.61.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last issued its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $3.21 by $0.08. The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business’s revenue was up 7.6% on a year-over-year basis. On average, sell-side analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.37 EPS for the current year.
Marsh & McLennan Companies Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Thursday, July 23rd will be given a $0.99 dividend. This represents a $3.96 dividend on an annualized basis and a yield of 2.2%. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio is presently 45.00%.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
